Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 August 2021 | Story Department of Communication and Marketing

Dear Student, 

As from today (20 August 2021), all people 18 years and older are eligible to be vaccinated against COVID-19. Register on the COVID-19 Vaccination Programme registration portal to get the vaccine.

Individuals aged 18 and older can get vaccinated at sites  across the country – including the Universitas Academic Hospital in Bloemfontein and retail stores such as Clicks and Dischem.

Remember, you can walk into any vaccination site to register and vaccinate. 

Here is a list of registered vaccination sites closest to the University of the Free State campuses: 
- Boikhuco Old Age Home – Bloemfontein (Mangaung)
- MUCPP Community Health Centre in Rocklands – Bloemfontein (Mangaung)x
- Pelonomi Hospital – Bloemfontein (Mangaung) 
- Standard Bank Building – Bloemfontein (Mangaung)
- Universitas Academic Hospital – Bloemfontein (Mangaung)
- Botshabelo Hospital – Botshabelo (Mangaung)
- Seemahale Secondary School – Botshabelo (Mangaung)
- Dr JS Moroka Hospital – Thaba Nchu (Mangaung)
- Dihlabeng Regional Hospital – Bethlehem, Dihlabeng (Thabo Mofutsanyana)
- Thabo Thokoza Secondary School – Dihlabeng (Thabo Mofutsanyana)
- Thekolohelong Old Age Home – Maluti-A-Phofung (Thabo Mofutsanyana)
- Senorita Nthlabathi District Hospital – Mantsopa (Thabo Mofutsanyana)
- Nketoana District Hospital – Nketoana (Thabo Mofutsanyana)
- Phumelela District Hospital – Phumelela (Thabo Mofutsanyana)

Vaccines are an important part of stopping the spread of COVID-19. Vaccines reduce the risk of getting a disease by working with your body to build protection. 

Need more information on vaccines? Read our COVID-19 Vaccine Information booklet here.

Visit the UFS COVID-19 webpage for updated information. 


News Archive

UFS Council unanimously reappoints Dr Khotso Mokhele as Chancellor
2015-04-02

 

Dr Khotso Mokhele, Chancellor of the University of the Free State

The Council of the University of the Free State (UFS) unanimously reappointed Dr Khotso Mokhele as Chancellor during its quarterly meeting held on 13 March 2015. He was first appointed in this portfolio by the Council on 4 June 2010.

“It is an honour for the Council to reappoint someone of this stature as Chancellor of the UFS. With his solid academic background and high profile in the business world, Dr Mokhele has been a great asset to the UFS. On behalf of the Council and the university community, I extend a word of appreciation for the work he has done during his first term as Chancellor of the UFS. He is an exceptional leader, and the university community is looking forward to have him as Chancellor for a second term,” said Judge Ian van der Merwe, Chairperson of the UFS Council.

Dr Mokhele was awarded a BSc Agriculture from Fort Hare University, and continued his studies at the University of California Davis (USA) on the Fulbright-Hays Scholarship Programme, completing his MSc (Food Science) and PhD (Microbiology). He was subsequently a postdoctoral fellow at Johns Hopkins University School of Medicine (USA) and the University of Pennsylvania School of Medicine (USA). Dr Mokhele is the recipient of honorary doctorates from nine South African universities including the UFS, and from Rutgers University in the USA.

He was Chairman of the Rhodes Scholarship Selection Committee for Botswana, Malawi, Namibia, Lesotho and Swaziland (2007-2011), and served on the South Africa at Large Rhodes Scholarship Selection Committee for more than 10 years. As President and Chief Executive Officer (CEO) of the Foundation for Research Development (1996-1999) and the NRF from 1999 to 2006, Dr Mokhele played a central role in providing visionary and strategic direction to the South African science system. He was the Founder President of the Academy of Science of South Africa (ASSAf), Founder President and CEO of the National Research Foundation (NRF), Chairperson of the Economic Advisory Council to the Premier of the Free State (2001-2004), and a member of the Advisory Council on Innovation to the Minister of Science and Technology (2003-2007). His role in securing government and international support for the Southern African Large Telescope Project (SALT) is evidence of his dedication to science in South Africa. The success of this project laid the basis for South Africa being selected to host more than 70% of the Square Kilometre Array, an international mega telescope for radio astronomy.

In recognition of his contribution to the development of science, he was the recipient of the Technology Top 100 Lifetime Achievers Award in 2009 and the National Science and Technology Forum Award in 2005. His role in science is recognised internationally. He was an elected Vice-President: Scientific Planning and Review of the International Council for Science and Chairperson of its Committee for Scientific Planning and Review (2005-2008) as well as a member of the Committee on Developing and Transition Economy Countries of the International Social Science Council (2008-2010). He also represented South Africa on the executive board of UNESCO, and was awarded the Member Legion of Honour of the Republic of France for his work in strengthening scientific ties between South Africa and France.

Dr Mokhele currently serves as Special Advisor to the Minister of Science and Technology, the Honourable Naledi Pandor. His current corporate positions include: Non-Executive Chairman: Board of Directors, Impala Platinum Holdings Ltd (Implats); Lead Independent Non-Executive Director: African Oxygen Ltd (Afrox); Non-Executive Director of Zimbabwe Platinum Holdings Ltd (Zimplats); Hans Merensky Holdings Ltd; and Tiger Brands Ltd. He is the President of the Hans Merensky Foundation (South Africa) and a Trustee of SciDev.Net (a web-based scientific magazine based in London, UK) and Start International Inc (USA).

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept